by Prakash Achaary | Aug 27, 2020 | Blog
Whitepaper: Best Practices for FDA Orphan Drug Designation Applications [Fill out the form below to access the whitepaper] The Orphan Drug Act, established in 1983, provides incentives to sponsors for promoting the development of drugs for the prevention, diagnoses,...
by Don McLean | May 29, 2020 | Blog
Pharmaceutical Industry News Roundup: May 2020 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from May: Coronavirus (COVID-19) Update: FDA Collaborations Promote Rigorous Analyses of Real-World...
by Don McLean | May 5, 2020 | News
GREEN VALLEY PHARMACEUTICAL AND MMS HOLDINGS COLLABORATE TO GAIN FDA APPROVAL TO BEGIN CLINICAL TRIALS FOR THE FIRST ALZHEIMER’S DRUG IN 17 YEARS CANTON, Mich. and SHANGHAI (May 5, 2020) – MMS Holdings Inc. (MMS) – an award-winning, data-focused CRO – announced that a...
by Don McLean | Mar 25, 2020 | Blog
Pharmaceutical Industry News Roundup: March 2020 by Staff Writer Each month, MMS shares key stories on the evolution of the pharmaceutical industry. Here is a selection from March: Coronavirus (COVID-19) Update: FDA continues to facilitate development of...
by Don McLean | Mar 4, 2020 | News
MMS Holdings to Debut Datacise Integrated Safety Explorer to Detect Safety Signals Using Real-World Evidence During PHUSE/FDA Data Science Innovation Challenge CANTON, Mich. (March 4, 2020) – MMS Holdings (MMS) – an award-winning, data-focused CRO – announced today...
